Characteristics of Patients Who Achieve Serum Phosphorus Control on Sucroferric Oxyhydroxide or Sevelamer Carbonate: A post hoc Analysis of a Phase 3 Study

INTRODUCTION: Control of hyperphosphatemia in patients on dialysis remains a major challenge. OBJECTIVE: This study evaluated predictors of serum phosphorus (sP) control among dialysis patients treated with noncalcium, oral phosphate binder therapy in a phase 3 clinical trial. METHODS: Post hoc anal...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Nephron Clin Pract
Prif Awduron: Covic, Adrian C., Sprague, Stuart M., Rastogi, Anjay, Ketteler, Markus, Walpen, Sebastian, Perrin, Amandine, Floege, Jürgen
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: S. Karger AG 2020
Pynciau:
Clinical Practice: Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7592954/
https://ncbi.nlm.nih.gov/pubmed/32585670
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000507258
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg